MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

Rajani Kanteti; Immanuel Dhanasingh; Ichiro Kawada; Frances E. Lennon; Qudsia Arif; Raphael Bueno; Rifat Hasina; Aliya N. Husain; Wickii Vigneswaran; Tanguy Seiwert; Hedy L. Kindler; Ravi Salgia

doi:10.1371/journal.pone.0105919

Loading metrics

Open Access

Peer-reviewed

Research Article

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

Rajani Kanteti,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Immanuel Dhanasingh,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Ichiro Kawada,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Frances E. Lennon,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Qudsia Arif,

Affiliation Department of Pathology, University of Chicago, Chicago, Illinois, United States of America
⨯
Raphael Bueno,

Affiliation Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Rifat Hasina,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Aliya N. Husain,

Affiliation Department of Pathology, University of Chicago, Chicago, Illinois, United States of America
⨯
Wickii Vigneswaran,

Affiliation Department of Surgery, University of Chicago, Chicago, Illinois, United States of America
⨯
Tanguy Seiwert,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Hedy L. Kindler,

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯
Ravi Salgia

* E-mail: rsalgia@medicine.bsd.uchicago.edu

Affiliation Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America
⨯

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

Rajani Kanteti,
Immanuel Dhanasingh,
Ichiro Kawada,
Frances E. Lennon,
Qudsia Arif,
Raphael Bueno,
Rifat Hasina,
Aliya N. Husain,
Wickii Vigneswaran,
Tanguy Seiwert

Published: September 15, 2014
https://doi.org/10.1371/journal.pone.0105919

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Mesothelioma
Is the Subject Area "Mesothelioma" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell motility
Is the Subject Area "Cell motility" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Signal inhibition
Is the Subject Area "Signal inhibition" applicable to this article?

Thanks for your feedback.